Invalid Symbol

Stock Research for EXAS

EXAS
Current Price

$


Latest Update:

High
$
Low
$
Close
$
Volume
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

EXAS Stock Chart & Research Data

The EXAS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the EXAS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


EXAS Due diligence Resources & Stock Charts

The EXAS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View EXAS Detailed Price Forecast - CNN Money CNN View EXAS Detailed Summary - Google Finance
Yahoo View EXAS Detailed Summary - Yahoo! Finance Zacks View EXAS Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View EXAS Trends & Analysis - Trade-Ideas Barrons View EXAS Major Holders - Barrons
NASDAQ View EXAS Call Transcripts - NASDAQ Seeking View EXAS Breaking News & Analysis - Seeking Alpha
Spotlight View EXAS Annual Report - CompanySpotlight.com OTC Report View EXAS OTC Short Report - OTCShortReport.com
TradeKing View EXAS Fundamentals - TradeKing Charts View EXAS SEC Filings - Bar Chart
WSJ View Historical Prices for EXAS - The WSJ Morningstar View Performance/Total Return for EXAS - Morningstar
MarketWatch View the Analyst Estimates for EXAS - MarketWatch CNBC View the Earnings History for EXAS - CNBC
StockMarketWatch View the EXAS Earnings - StockMarketWatch MacroAxis View EXAS Buy or Sell Recommendations - MacroAxis
Bullish View the EXAS Bullish Patterns - American Bulls Short Pains View EXAS Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View EXAS Stock Mentions - StockTwits PennyStocks View EXAS Stock Mentions - PennyStockTweets
Twitter View EXAS Stock Mentions - Twitter Invest Hub View EXAS Investment Forum News - Investor Hub
Yahoo View EXAS Stock Mentions - Yahoo! Message Board Seeking Alpha View EXAS Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for EXAS - SECform4.com Insider Cow View Insider Transactions for EXAS - Insider Cow
CNBC View EXAS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for EXAS - OTC Markets
Yahoo View Insider Transactions for EXAS - Yahoo! Finance NASDAQ View Institutional Holdings for EXAS - NASDAQ


Stock Charts

FinViz View EXAS Stock Insight & Charts - FinViz.com StockCharts View EXAS Investment Charts - StockCharts.com
BarChart View EXAS Stock Overview & Charts - BarChart Trading View View EXAS User Generated Charts - Trading View


Latest Financial News for EXAS

Is the Options Market Predicting a Spike in Exact Sciences (EXAS) Stock?
Posted on Wednesday February 21, 2018

Surging implied volatility makes Exact Sciences (EXAS) stock lucrative to the option traders.


Why Earnings Season Could Be Great for Exact Sciences (EXAS)
Posted on Wednesday February 21, 2018

Exact Sciences (EXAS) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.


See what the IHS Markit Score report has to say about Exact Sciences Corp.
Posted on Thursday February 15, 2018

Exact Sciences Corp NASDAQ:EXAS


Exact Sciences schedules fourth-quarter, full-year 2017 earnings call
Posted on Thursday February 08, 2018

MADISON, Wis., Feb. 8, 2018 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company plans to release its fourth-quarter and full-year 2017 financial results after the close of the U.S. financial markets on Feb. 22. Following the release, company management will host a webcast and conference call at 5 p.m. Eastern time to discuss financial results and business progress.


Earnings Preview: Exact Sciences
Seeking Alpha - Feb 19, 2018
Strong Cologuard test volumes reported by Exact Sciences (EXAS) in the last quarter sent its share soaring to the $60 level.
Technical Indicators under Review – Exact Sciences Corporation (NASDAQ: EXAS) - Alpha Beta Stock
Exact Sciences Corporation (EXAS) Analysts See $-0.29 EPS - BZ Weekly

Two sizzlers stock's are not to be missed: Exact Sciences Corporation (EXAS ...
StockNewsJournal - 5 hours ago
Exact Sciences Corporation (NASDAQ:EXAS) market capitalization at present is $5.78B at the rate of $48.01 a share. The firm's price-to-sales ratio was noted 27.36 in contrast with an overall industry average of 141.46.
Why Earnings Season Could Be Great for Exact Sciences (EXAS) February 21, 2018 - Zacks.com
Exact Sciences Corporation (EXAS) EPS Estimated At $-0.27 - BZ Weekly

EXACT Sciences Corp.: We Admit To Being Early; But The Science Won't Be Held Back
Seeking Alpha - Jan 29, 2018
CellMax, a company you never heard of 8 months ago, just put out a press release that should make all Exact Sciences (NASDAQ:EXAS) shareholders poop in their pants. As you read this article, the CellMax CEO was just on stage at the 2018 Precision ...
Is It Time to go for Exact Sciences Corporation (EXAS), Microchip Technology ... - StockNewsJournal
Exact Sciences, Generic Drugs, WEDC & More: This Week's WI Watchlist - Xconomy

Could Exact Sciences Corporation Be a Millionaire-Maker Stock?
Motley Fool - Feb 7, 2018
Exact Sciences' immediate opportunity is tremendous. The company's Cologuard is the first and only FDA-approved DNA screening test for colorectal cancer.
Exact Sciences schedules fourth-quarter, full-year 2017 earnings call - PR Newswire (press release)
2 Stocks to keep an eye on Today: Exact Sciences Corporation (EXAS), Aetna Inc ... - StockNewsJournal

Enter a stock symbol to view the stock details.